Replacement therapy for
Primary immunodeficiency diseases (PID),
Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections,
Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
Immunomodulatory therapy for
Idiopathic thrombocytopenic purpura (ITP) in patients at high risk of bleeding or prior to surgery to correct the platelet count,
Guillain-Barr Syndrome (GBS),
Kawasaki disease,
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),
Multifocal Motor Neuropathy (MMN),
Myasthenia Gravis (MG) exacerbations,
Lambert-Eaton Myasthenic Syndrome (LEMS),
Stiff Person Syndrome (SPS).
How to take it
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Store below 25 degrees Celsius
Do not Freeze
Protect from Light
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Clear or slightly opalescent and colourless or pale yellow solution
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Replacement therapy for
Primary immunodeficiency diseases (PID),
Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections,
Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
Immunomodulatory therapy for
Idiopathic thrombocytopenic purpura (ITP) in patients at high risk of bleeding or prior to surgery to correct the platelet count,
Guillain-Barr Syndrome (GBS),
Kawasaki disease,
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),
Multifocal Motor Neuropathy (MMN),
Myasthenia Gravis (MG) exacerbations,
Lambert-Eaton Myasthenic Syndrome (LEMS),
Stiff Person Syndrome (SPS).
How to take it
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Store below 25 degrees Celsius
Do not Freeze
Protect from Light
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Clear or slightly opalescent and colourless or pale yellow solution
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Replacement therapy for
Primary immunodeficiency diseases (PID),
Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections,
Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
Immunomodulatory therapy for
Idiopathic thrombocytopenic purpura (ITP) in patients at high risk of bleeding or prior to surgery to correct the platelet count,
Guillain-Barr Syndrome (GBS),
Kawasaki disease,
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),
Multifocal Motor Neuropathy (MMN),
Myasthenia Gravis (MG) exacerbations,
Lambert-Eaton Myasthenic Syndrome (LEMS),
Stiff Person Syndrome (SPS).
How to take it
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Store below 25 degrees Celsius
Protect from Light
Do not Freeze
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Clear or slightly opalescent and colourless or pale yellow solution
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Replacement therapy for
Primary immunodeficiency diseases (PID),
Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections,
Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
Immunomodulatory therapy for
Idiopathic thrombocytopenic purpura (ITP) in patients at high risk of bleeding or prior to surgery to correct the platelet count,
Guillain-Barr Syndrome (GBS),
Kawasaki disease,
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),
Multifocal Motor Neuropathy (MMN),
Myasthenia Gravis (MG) exacerbations,
Lambert-Eaton Myasthenic Syndrome (LEMS),
Stiff Person Syndrome (SPS).
How to take it
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
Store below 25 degrees Celsius
Do not Freeze
Protect from Light
Shelf lifetime is 3 Years.
Store below 25 degrees Celsius
Do not Freeze
Protect from Light
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Clear or slightly opalescent and colourless or pale yellow solution
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
Support for this browser is being discontinued
Support for this browser is being discontinued for this site
Internet Explorer 11 and lower
We currently support Microsoft Edge, Chrome, Firefox and Safari. For more information, please visit the links below:
